Allergy, Asthma, and Atopic Eczema in Finland (FinnATOPY)

March 19, 2024 updated by: Peter Csonka, Tampere University

Allergy, Asthma, and Atopic Eczema in Finland - A Nationwide Study on Prevalence, Comorbidities, Treatment and Economic Burden

The summary is available at --> https://www.finnatopy.fi/summary

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Aims and objectives ---> https://www.finnatopy.fi/aims-and-objectives Methods ---> https://www.finnatopy.fi/methods

Study Type

Observational

Enrollment (Estimated)

2000000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Finland
      • Tampere, Finland
        • Tampere University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

https://www.finnatopy.fi/methods

Description

Inclusion/Exclusion Criteria ---> https://www.finnatopy.fi/methods

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Epidemiology of atopic diseases and allergic sensitization profiles in Finland
Time Frame: 7 years
Incidence and prevalence of asthma, specific IgE sensitization, atopic dermatitis, allergic rhinitis
7 years
Burden of atopic diseases (allergies, asthma, and atopic eczema) as well as comorbidities in Finland
Time Frame: 7 years
Morbidity, sick leaves, medication use, costs and expences
7 years
Evaluate and improve the current use of diagnostic tests for atopic diseases
Time Frame: 7 years
Diagnostic practices, tests for allergic sensitization, lung function tests, and other laboratory measures.
7 years
Use and effectiveness of allergen immunotherapy in real world setting
Time Frame: 7 years
Real world evidence data using specific cohorts
7 years
Direct and indirect costs related to atopic diseases and comorbidities
Time Frame: 7 years
All costs, including sick leaves, absenteeism, laboratory costs, other diagnisteic tests, etc.
7 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tampere University

Collaborators

Professor Lauri Lehtimäki
Professor Mika Mäkelä
Professor Sanna Toppila-Salmi
Professor Ilkka Junttila

Investigators

  • Principal Investigator: Péter Csonka, Tampere University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2024

Primary Completion (Estimated)

December 1, 2032

Study Completion (Estimated)

December 1, 2034

Study Registration Dates

First Submitted

March 12, 2024

First Submitted That Met QC Criteria

March 19, 2024

First Posted (Actual)

March 26, 2024

Study Record Updates

Last Update Posted (Actual)

March 26, 2024

Last Update Submitted That Met QC Criteria

March 19, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FinnATOPY

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

Clinical Trials on No intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe